1. Home
  2. CAN vs OCGN Comparison

CAN vs OCGN Comparison

Compare CAN & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • OCGN
  • Stock Information
  • Founded
  • CAN 2013
  • OCGN 2013
  • Country
  • CAN Singapore
  • OCGN United States
  • Employees
  • CAN N/A
  • OCGN N/A
  • Industry
  • CAN Semiconductors
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CAN Technology
  • OCGN Health Care
  • Exchange
  • CAN Nasdaq
  • OCGN Nasdaq
  • Market Cap
  • CAN 330.5M
  • OCGN 321.7M
  • IPO Year
  • CAN 2019
  • OCGN N/A
  • Fundamental
  • Price
  • CAN $0.81
  • OCGN $1.32
  • Analyst Decision
  • CAN Strong Buy
  • OCGN Strong Buy
  • Analyst Count
  • CAN 6
  • OCGN 3
  • Target Price
  • CAN $2.50
  • OCGN $6.00
  • AVG Volume (30 Days)
  • CAN 25.3M
  • OCGN 2.6M
  • Earning Date
  • CAN 08-14-2025
  • OCGN 11-07-2025
  • Dividend Yield
  • CAN N/A
  • OCGN N/A
  • EPS Growth
  • CAN N/A
  • OCGN N/A
  • EPS
  • CAN N/A
  • OCGN N/A
  • Revenue
  • CAN $345,360,000.00
  • OCGN $4,754,000.00
  • Revenue This Year
  • CAN $90.25
  • OCGN N/A
  • Revenue Next Year
  • CAN $42.94
  • OCGN N/A
  • P/E Ratio
  • CAN N/A
  • OCGN N/A
  • Revenue Growth
  • CAN 82.40
  • OCGN N/A
  • 52 Week Low
  • CAN $0.53
  • OCGN $0.52
  • 52 Week High
  • CAN $3.27
  • OCGN $1.33
  • Technical
  • Relative Strength Index (RSI)
  • CAN 59.68
  • OCGN 78.94
  • Support Level
  • CAN $0.77
  • OCGN $1.00
  • Resistance Level
  • CAN $0.85
  • OCGN $1.25
  • Average True Range (ATR)
  • CAN 0.04
  • OCGN 0.05
  • MACD
  • CAN 0.01
  • OCGN 0.03
  • Stochastic Oscillator
  • CAN 77.32
  • OCGN 96.97

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: